15-Year watch begins for CAR T-Cell therapy patients

NCT ID NCT06652633

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 25 times

Summary

This study follows people who have already been treated with a Galapagos CAR T-cell therapy for blood cancers. Researchers will check for long-term side effects and how well the treatment works over 15 years. No new treatment is given—just regular monitoring. About 546 participants will join.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOLOGICAL MALIGNANCIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Academisch Medisch Centrum

    RECRUITING

    Amsterdam, 1105 AZ, Netherlands

  • Amsterdam UMC

    RECRUITING

    Amsterdam, 1081 HV, Netherlands

  • Antwerp University Hospital

    RECRUITING

    Edegem, 2650, Belgium

  • Centre Hospitalier Universitaire (CHU) De Liège

    RECRUITING

    Liège, 4032, Belgium

  • Hospital Clinic De Barcelona

    RECRUITING

    Barcelona, 08036, Spain

  • Leids University Medical Center (LUMC)

    RECRUITING

    Leiden, 2333 ZA, Netherlands

Conditions

Explore the condition pages connected to this study.